Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2017

Sep 7, 2017

30237_dirs_2017-09-07_71c880e8-559e-47a4-889c-de856ff66711.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-08-02

Reporting Person: KING DAVID P (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-02 Common Stock G 1650 Disposed 214065.582 Direct
2017-09-05 Common Stock M 132713 $90.74 Acquired 346778.582 Direct
2017-09-05 Common Stock S 132713 $157.056 Disposed 214065.582 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-05 Non-qualified Stock Options $90.74 M 132713 Disposed 2021-02-09 Common Stock (132713) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9042 Indirect
Common Stock 31601 Indirect
Common Stock 1014 Indirect

Footnotes

F1: Amount includes 156.9666 shares acquired on June 30, 2017 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan and annuity payments from each of the reporting person's grantor retained annuity trusts to the reporting person in the amounts and on the dates indicated in notes 4 and 5 below.

F2: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F3: The price of $157.0560 per share represents a weighted average of sales prices ranging from $157.00 to $157.48 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: Amount reflects an annuity payment of 7,900 shares made by the trust to the reporting person on July 11, 2017.

F5: Amount reflects an annuity payment of 9,300 shares made by the trust to the reporting person on July 17, 2017.

F6: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F7: The option vested in three equal annual installments beginning on 02/09/2011 and is now fully exercisable.